Theresa Janke
Fondatore presso 4D MOLECULAR THERAPEUTICS, INC.
Posizioni attive di Theresa Janke
Società | Posizione | Inizio | Fine |
---|---|---|---|
4D MOLECULAR THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | 12/09/2013 | - |
Fondatore | 12/09/2013 | - | |
Direttore operativo | 01/04/2018 | 01/02/2020 | |
Public Communications Contact | - | - | |
Corporate Officer/Principal | 01/02/2020 | 01/06/2021 |
Storia della carriera di Theresa Janke
Precedenti posizioni note di Theresa Janke
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Direttore/Membro del Consiglio | - | 01/10/2019 |
Fondatore | - | 01/10/2019 | |
SILLAJEN, INC. | Corporate Officer/Principal | 01/01/2013 | 01/01/2014 |
CELGENE | Direttore Tecnico/Scientifico/R&S | 01/01/2013 | 01/01/2014 |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2007 | 01/01/2013 |
Formazione di Theresa Janke
University of California, Santa Barbara | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Corea del Sud | 2 |
Posizioni
Founder | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SILLAJEN, INC. | Health Technology |
4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
- Borsa valori
- Insiders
- Theresa Janke
- Esperienza